Genmab A/S Dkk

(GNMSF)

By |

Profile

Genmab is a cancer drug developer, best known for its antibody technology platforms, DuoBody and HexaBody, and its promising first-in-class multiple myeloma drug Darzalex (daratumumab), which is partnered with J&J. The company also has several pipeline candidates targeting other oncologic indications and autoimmune diseases.

Contact Information

Website: www.genmab.com
Email: r.gravesen@genmab.com
Main Phone: +45 70202728
Address: Kalvebod Brygge 43
Address 2: 1560
City / Town: Copenhagen V
Country: DNK
Postal Code: 1260

Issuer Information

Exchange: OTO
Employees: 309
$ 154.95 $ 0. (0.00%)
Last Price 154.95 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 154.95
Last Trade Volume 3,095 52 Wk Hi 213.00 52 Wk Low 119.10
Market Cap 9.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,397,571.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 51.98 51.98 51.98 13.68
Low Target Price Estimate 51.98 51.98 51.98 13.68
Mean Target Price Estimate 51.98 51.98 51.98 13.68
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/23/07 08/23/07 08/23/07 04/28/10
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1